Amyloid Plaque and Tangle Imaging in Aging and Dementia
NCT00355498 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 170
Last updated 2020-05-06
Summary
Amyloid senile plaques (SPs) and neurofibrillary tangles (NFTs) are neuropathological hallmarks of Alzheimer's disease (AD) that also accumulate in key brain regions in association with normal aging. This project will expand an established program in early detection and prevention of AD designed (1) to identify presymptomatic persons most likely to benefit from early intervention and (2) to provide an objective, noninvasive means to monitor therapeutic trials.
Conditions
- Memory Disorders
- Alzheimer's Disease
Sponsors & Collaborators
-
National Institute on Aging (NIA)
collaborator NIH -
University of California, Los Angeles
lead OTHER
Principal Investigators
-
Gary W. Small, MD · University of California, Los Angeles, Neuropsychiatric Institute
Eligibility
- Min Age
- 30 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2005-09-30
- Primary Completion
- 2010-05-31
- Completion
- 2010-05-31
Countries
- United States
Study Locations
More Related Trials
-
Molecular and Structural Imaging in Alzheimer's Disease: A Longitudinal Study
NCT02740634 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Imaging Tau in Alzheimer's Disease and Normal Aging
NCT03373604 ·Status: COMPLETED ·Phase: PHASE2
-
Imaging Tau in Alzheimer's Disease and Normal Aging
NCT02884492 ·Status: TERMINATED ·Phase: PHASE2
-
Early Diagnosis of Alzheimer's Disease: Clinical, Neuropsychological and Neuroimaging Follow-up of a Cohort of Patients With an Isolated Memory Impairment
NCT00684281 ·Status: COMPLETED ·Phase: NA
-
Memory Imaging of Normal Aging
NCT00315575 ·Status: COMPLETED
-
FluoroAv45 Imaging Research-in Alzheimer's Disease
NCT01325259 ·Status: COMPLETED ·Phase: PHASE2
-
Imaging of Brain Amyloid Plaques in the Aging Population
NCT00950430 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE4
-
Study to Evaluate Amyloid in Blood and Imaging Related to Dementia
NCT03899844 ·Status: COMPLETED
-
Assess 123-I IMPY and SPECT Imaging as a Tool to Detect β-Amyloid in the Brain
NCT00287248 ·Status: COMPLETED ·Phase: PHASE1
-
Neuroimaging Markers of Alzheimer Disease: a Longitudinal Population Study
NCT01582919 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Age- and Alzheimer's Disease-Related Memory Disorder
NCT00029120 ·Status: COMPLETED
-
Safety and Efficacy of Positron Emission Tomography (PET) Imaging With MNI-558
NCT01217021 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Positron Emission Tomography of Amyloid in Alzheimer's Disease
NCT00205621 ·Status: SUSPENDED ·Phase: PHASE1
-
Evaluating the Relationship Between Tau PET Imaging and CSF Biomarkers of AD (Alzheimer Disease) in Humans
NCT03287765 ·Status: COMPLETED
-
New Imaging Biomarkers Predictive of MA Progression
NCT05939362 ·Status: RECRUITING ·Phase: NA
-
Biomarkers and Early Alzheimer's Disease
NCT00094952 ·Status: UNKNOWN
-
Evaluation of Alteration by Magnetic Resonance Imaging (MRI) in Dementia Among Elderly Subjects
NCT00951197 ·Status: COMPLETED
-
Magnetic Resonance Imaging for the Study of Patients With Neurological Disorders
NCT00001362 ·Status: COMPLETED
-
Neuro Imaging and Multimodal Alzheimer's Disease
NCT02839187 ·Status: COMPLETED ·Phase: NA
-
PET Imaging Tau Accumulation in FTLD and Atypical Alzheimer's Using [18F]-PI-2620
NCT05456503 ·Status: RECRUITING ·Phase: PHASE3
-
Imaging Biomarkers in Preclinical and Symptomatic AD
NCT04134923 ·Status: RECRUITING
-
Imaging Inflammation in Alzheimer's Disease
NCT02831283 ·Status: COMPLETED ·Phase: PHASE2
-
Multi-modal Neuroimaging in Alzheimer's Disease IMAP+
NCT01638949 ·Status: COMPLETED ·Phase: NA
-
New Biomarker for Alzheimer's Disease Diagnostic
NCT01315639 ·Status: COMPLETED ·Phase: NA
-
Activity of Cerebral Networks, Amyloid and Microglia in Aging and Alzheimer's Disease
NCT06224920 ·Status: COMPLETED